Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    24628789 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules
Condition: Influenza
Intervention: Biological: Pandemic influenza vaccine GSK1562902A
2 Completed Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults
Condition: Influenza
Intervention: Biological: Influenza Vaccine GSK1562902A - 6 different formulations

Study has passed its completion date and status has not been verified in more than two years.